John Dobak, Chief Executive Officer at DermTech, Inc. (DMTK), sold 47,201 shares at $4.06 ($192K) on 2023-03-07, disclosed to the SEC on 2023-03-09.
Seasonal sale ($192k) by Chief Executive Officer — this insider has traded DMTK in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.06 | 709 | $3K | 1.5% |
| 2 | $4.06 | 23,246 | $94K | 49.2% |
| 3 | $4.06 | 23,246 | $94K | 49.2% |
| Total | $4.06 avg | 47,201 | $192K | 100% |
| Filing → |
| DMTK | SELL | 2022-03-09 | $43K | — | Filing → |
| DMTK | SELL | 2021-12-16 | $33K | — | Filing → |
| DMTK | SELL | 2021-12-10 | $21K | — | Filing → |